Beaumont Financial Advisors’s Biogen BIIB Stock Holding History

Beaumont Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-841	Closed	-$238K	–	354
2021 Q3	$238K	Hold	841	–	–	0.02%	311
2021 Q2	$291K	Buy	841 +105	+14%	+$31.8K	0.02%	292
2021 Q1	$206K	Buy	+736	New	+$198K	0.02%	327
2020 Q4	–	Sell	-871	Closed	-$247K	–	335
2020 Q3	$247K	Buy	+871	New	+$243K	0.02%	282
2020 Q2	–	Sell	-854	Closed	-$270K	–	279
2020 Q1	$270K	Buy	854 +23	+3%	+$6.98K	0.03%	203
2019 Q4	$247K	Buy	+831	New	+$231K	0.02%	249
2015 Q4	–	Sell	-499	Closed	-$202K	–	126
2015 Q3	$202K	Hold	499	–	–	0.03%	131
2015 Q2	$202K	Buy	+499	New	+$200K	0.03%	131

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Beaumont Financial Advisors's BIIB Position: Q4 2021 in Review

Beaumont Financial Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 841 shares — an estimated $238K sold.

Beaumont Financial Advisors first reported a position in BIIB in Q2 2015 and held it in 8 quarters. The position peaked at $291K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Beaumont Financial Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Beaumont Financial Advisors sold 841 Biogen shares in Q4 2021, an estimated $238K.
Beaumont Financial Advisors first reported a position in Biogen in Q2 2015 and held it in 8 quarters.
Beaumont Financial Advisors's Biogen position peaked at $291K in Q2 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Beaumont Financial Advisors's 13F filing for Q4 2021, filed 7 Feb 2022.